• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form RW filed by Longview Acquisition Corp. II

    10/26/22 4:58:56 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials
    Get the next $LGV alert in real time by email
    RW 1 tm2229011-1_rw.htm RW

     

    Longview Acquisition Corp. II

    767 Fifth Avenue, 44th Floor

    New York, NY 10153

     

    October 26, 2022

     

    VIA EDGAR

    Securities and Exchange Commission

    Division of Corporation Finance

    100 F Street, N.E.

    Washington, D.C. 20549

     

      Re: Longview Acquisition Corp. II
        Request for Withdrawal of Registration Statement on Form S-4
        (File No. 333-258620)

     

    Ladies and Gentlemen:

     

    Pursuant to Rule 477 of the Securities Act of 1933, as amended (the “Securities Act”), Longview Acquisition Corp. II (the “Company”) hereby respectfully requests that the Company’s Registration Statement on Form S-4 (File No. 333-258620), together with all exhibits and amendments thereto (the “Registration Statement”), originally filed with the Securities and Exchange Commission (the “Commission”) on August 9, 2021, be withdrawn, effective as of the date hereof. The Company is withdrawing the Registration Statement because it no longer plans to consummate the business combination described in the Registration Statement. The Registration Statement has not been declared effective by the Commission, and no securities have been sold thereunder. Therefore, the Company believes that the withdrawal of the Registration Statement is consistent with the public interest and the protection of investors.

     

    The Company requests that, in accordance with Rule 457(p) of the Securities Act and subject to compliance with the requirements thereof, all fees paid to the Commission in connection with the filing of the Registration Statement be credited for potential future use.

     

    If you require any additional information, please contact Christopher J. Capuzzi of Ropes & Gray LLP at (212) 596-9575.

     

     

      Very truly yours,  
             
      LONGVIEW ACQUISITION CORP. II  
             
      By: /s/ Mark Horowitz  
        Name: Mark Horowitz  
        Title: Chief Financial Officer  

     

    cc: Ropes & Gray LLP
      Christopher J. Capuzzi

     

     

     

    Get the next $LGV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LGV

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LGV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Moore Westley was granted 2,000 shares

    4 - Longview Acquisition Corp. II (0001832300) (Issuer)

    11/9/22 8:13:23 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    $LGV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Longview Acquisition Corp. II Amends Charter and Trust Agreement to Redeem Public Shares Before Year-End and Announces December 14, 2022 as Amended Termination Date

    On December 14, 2022, Longview Acquisition Corp. II ("Longview" or "the Company") (NYSE:LGV, LGV and LGV WS))) stockholders approved (i) an amendment to Longview's Amended and Restated Certificate of Incorporation (the "Charter") (and the Charter, as amended, the "Second Amended and Restated Certificate of Incorporation") and (ii) and an amendment to Longview's Investment Trust Management Agreement, dated March 18, 2021, by and between the Company and Continental Stock Transfer & Trust Company, a New York limited purpose trust company ("Continental"), as trustee (the "Amendment to the Investment Trust Management Agreement") to allow Longview to (i) change the date by which the Company must

    12/14/22 4:02:00 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    HeartFlow Announces Mutual Termination of Business Combination Agreement

    REDWOOD CITY, Calif., Feb. 04, 2022 (GLOBE NEWSWIRE) -- HeartFlow Holding, Inc. ("HeartFlow"), the leader in revolutionizing precision heart care, today announced that it and Longview Acquisition Corporation II (NYSE:LGV), a special purpose acquisition company sponsored by affiliates of Glenview Capital Management, LLC, have mutually agreed to terminate their previously announced business combination agreement, effective immediately, as a result of current unfavorable market conditions.  About HeartFlowHeartFlow is the leader in revolutionizing precision heart care, uniquely combining human ingenuity with advanced technology. HeartFlow's non-invasive HeartFlow FFRct Analysis leverages art

    2/4/22 5:00:00 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company

    Transforming the way heart disease is diagnosed and treated, HeartFlow's artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients with heart disease, the most common type of cardiovascular disease which accounts for one in three deaths and $1 out of every $6 of U.S. healthcare spend1. HeartFlow has demonstrated higher diagnostic accuracy compared to other non-invasive tests2 with an 83% reduction in unnecessary invasive angiograms, resulting in a significant reduction in the total cost of care3. Merging with Longview Acq

    7/15/21 8:00:00 AM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    $LGV
    SEC Filings

    View All

    SEC Form 15-12G filed by Longview Acquisition Corp. II

    15-12G - Longview Acquisition Corp. II (0001832300) (Filer)

    1/9/23 4:16:12 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    SEC Form 25-NSE filed by Longview Acquisition Corp. II

    25-NSE - Longview Acquisition Corp. II (0001832300) (Subject)

    12/30/22 10:49:35 AM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    Longview Acquisition Corp. II filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

    8-K - Longview Acquisition Corp. II (0001832300) (Filer)

    12/20/22 4:17:11 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    $LGV
    Financials

    Live finance-specific insights

    View All

    HeartFlow, the Leader in Precision Heart Care, Announces Merger with Longview Acquisition Corp. II to Become a Publicly Traded Company

    Transforming the way heart disease is diagnosed and treated, HeartFlow's artificial intelligence-enabled software platform brings precision heart care to cardiology. The HeartFlow Analysis is the first and only non-invasive tool to assist with the diagnosis, management and treatment of patients with heart disease, the most common type of cardiovascular disease which accounts for one in three deaths and $1 out of every $6 of U.S. healthcare spend1. HeartFlow has demonstrated higher diagnostic accuracy compared to other non-invasive tests2 with an 83% reduction in unnecessary invasive angiograms, resulting in a significant reduction in the total cost of care3. Merging with Longview Acq

    7/15/21 8:00:00 AM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    $LGV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Longview Acquisition Corp. II (Amendment)

    SC 13G/A - Longview Acquisition Corp. II (0001832300) (Subject)

    2/6/23 12:25:45 PM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G filed by Longview Acquisition Corp. II

    SC 13G - Longview Acquisition Corp. II (0001832300) (Subject)

    2/15/22 9:54:06 AM ET
    $LGV
    Consumer Electronics/Appliances
    Industrials